Zahra Ahmadinejad

Prof. Zahra Ahmadinejad


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2004 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ATAnahita Tavoosi
Anahita Tavoosi
AZAzadeh Zaferani
Azadeh Zaferani
AEAnahita Enzevaei
Anahita Enzevaei
PTParvin Tajik
Parvin Tajik
ZAZahra Ahmadinejad
Zahra Ahmadinejad
Young people are of particular importance in state policies against Acquired Immunodeficiency Syndrome (AIDS). We intended to assess the knowledge and attitude of high school students regarding AIDS in Iran. Through a cluster-sampling, 4641 students from 52 high schools in Tehran were assessed by anonymous questionnaires in February 2002. The students identified television as their most important source of information about AIDS. Only a few students answered all the knowledge questions correctly, and there were many misconceptions about the routes of transmission. Mosquito bites (33%), public swimming pools (21%), and public toilets (20%) were incorrectly identified as routes of transmission. 46% believed that Human Immunodeficiency Virus positive (HIV positive) students should not attend ordinary schools. Most of the students wanted to know more about AIDS. In this study knowledge level was associated with students' attitudes and discipline (p < 0.001). Although the knowledge level seems to be moderately high, misconceptions about the routes of transmission were common. There was a substantial intolerant attitude towards AIDS and HIV positive patients. We recommend that strategies for AIDS risk reduction in adolescents be developed in Iranian high schools.

1 May 2006
Verified
Journal Article
Closed access
VZVahid Ziaee
Vahid Ziaee
MRM Razaei
M Razaei
ZAZahra Ahmadinejad
Zahra Ahmadinejad
HSH Shaikh
H Shaikh
RYR Yousefi
R Yousefi
MBM J Behjati
M J Behjati

6 May 2021 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
LALadan Abbasian
Ladan Abbasian
MSMohammad Solduzian
Mohammad Solduzian
NYNiloofar Ayoobi Yazdi
Niloofar Ayoobi Yazdi
FJFatemeh Jafari
Fatemeh Jafari
MRMehrnaz Rasoolinejad
Mehrnaz Rasoolinejad
Background: The clinical course of COVID-19 may vary significantly. The presence of comorbidities prolongs the recovery time. The recovery in patients with mild-to-moderate symptoms might take 10 days, while in those with a critical illness or immunocompromised status could take 15 days. Considering the lack of data about predictors that could affect the recovery time, we conducted this study to identify them. Methods: This cross-sectional study was implemented in the COVID-19 clinic of a teaching and referral university hospital in Tehran. Patients with the highly suggestive symptoms who had computed tomography (CT) imaging results with typical findings of COVID-19 or positive results of reverse transcriptase-polymerase chain reaction (RT-PCR) were enrolled in the study. Inpatient and outpatient COVID-19 participants were followed up by regular visits or phone calls, and the recovery period was recorded. Results: A total of 478 patients were enrolled. The mean age of patients was 54.11 ± 5.65 years, and 44.2% were female. The median time to recovery was 13.5 days (IQR: 9). Although in the bivariate analysis, multiple factors, including hypertension, fever, diabetes mellitus, gender, and admission location, significantly contributed to prolonging the recovery period, in multivariate analysis, only dyspnea had a significant association with this variable (p = 0.02, the adjusted OR of 2.05; 95% CI 1.12–3.75). Conclusion: This study supports that dyspnea is a predictor of recovery time. It seems like optimal management of the comorbidities plays the most crucial role in recovery from COVID-19.

1 December 2003 in Wilderness & Environmental Medicine
Verified
Journal Article
Closed access
VZVahid Ziaee
Vahid Ziaee
MYMasud Yunesian
Masud Yunesian
ZAZahra Ahmadinejad
Zahra Ahmadinejad
FHFarzin Halabchi
Farzin Halabchi
RKRamin Kordi
Ramin Kordi
HAHamid Reza Afsharjoo
Hamid Reza Afsharjoo
Many trekkers up Mount Damavand run the risk of developing acute mountain sickness (AMS); however, not much is documented concerning the incidence of AMS and its related factors within this population. We designed this study to determine the incidence and risk factors for AMS in trekkers around Mount Damavand in Iran. Symptoms of AMS and the contributing factors were assessed in the course of 6 weeks in summer 2000. Standard Lake Louise questionnaires were administered to 459 subjects, all of whom were trekkers. The questionnaires were filled out in 3 steps, first at 2900 m and then during both ascent and descent at 4200 m. The overall incidence of AMS was 60.8%. The incidence was higher in residents who lived at an altitude less than 600 m, amateur trekkers, those with a previous history of AMS, those with a history of AMS at ascent to Damavand, and those with night ascents (6 PM to midnight). Incidence was weakly dependent on rate of ascent (from 2900 m up to 4200 m in less than 4 hours) and sleep at 4200 m. No significant association was found between AMS and sex, age, body mass index, height, weight, smoking, weight of knapsacks, or the spent time in the shelter (at 4200 m). We conclude that the incidence of AMS is high in Iranian trekkers ascending Mount Damavand. Some of the contributing factors are preventable, so we suggest considering an educational program for trekkers to high altitudes in Iran.

26 January 2014 in Asian Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
ZAZahra Ahmadinejad
Zahra Ahmadinejad
NANeda Alijani
Neda Alijani
SMSedigeh Mansori
Sedigeh Mansori
VZVahid Ziaee
Vahid Ziaee
There is a relationship between exercise and changes in immunity. So athletes are prone to different medical problems such as injuries and infections. Infection is an important medical problem which could be a reason for athletes absence from training. The relationship between physical activity and immune system, characteristics of different types of infections in athletes with emphasis on special clinical presentations or complications, time to return to physical activity and training and strategies to prevent development and transmission of infections in athletes or physically active people are the main topics of this review.

18 November 2021 in Virology Journal
Verified
Journal Article
Open access
PDF file
NYNiloofar Ayoobi Yazdi
Niloofar Ayoobi Yazdi
AGAbdolkarim Haji Ghadery
Abdolkarim Haji Ghadery
SSSeyedAhmad SeyedAlinaghi
SeyedAhmad SeyedAlinaghi
FJFatemeh Jafari
Fatemeh Jafari
SJSirous Jafari
Sirous Jafari
LALadan Abbasian
Ladan Abbasian
Background: Since the COVID-19 outbreak, pulmonary involvement was one of the most significant concerns in assessing patients. In the current study, we evaluated patient’s signs, symptoms, and laboratory data on the first visit to predict the severity of pulmonary involvement and their outcome regarding their initial findings. Methods: All referred patients to the COVID-19 clinic of a tertiary referral university hospital were evaluated from April to August 2020. Four hundred seventy-eight COVID-19 patients with positive real-time reverse-transcriptase-polymerase chain reaction (RT-PCR) or highly suggestive symptoms with computed tomography (CT) imaging results with typical findings of COVID-19 were enrolled in the study. The clinical features, initial laboratory, CT findings, and short-term outcomes (ICU admission, mortality, length of hospitalization, and recovery time) were recorded. In addition, the severity of pulmonary involvement was assessed using a semi-quantitative scoring system (0–25). Results: Among 478 participants in this study, 353 (73.6%) were admitted to the hospital, and 42 (8.7%) patients were admitted to the ICU. Myalgia (60.4%), fever (59.4%), and dyspnea (57.9%) were the most common symptoms of participants at the first visit. A review of chest CT scans showed that Ground Glass Opacity (GGO) (58.5%) and consolidation (20.7%) were the most patterns of lung lesions. Among initial clinical and laboratory findings, anosmia (P = 0.01), respiratory rate (RR) with a cut point of 25 (P = 0.001), C-reactive protein (CRP) with a cut point of 90 (P = 0.002), white Blood Cell (WBC) with a cut point of 10,000 (P = 0.009), and SpO2 with a cut point of 93 (P = 0.04) was associated with higher chest CT score. Lung involvement and consolidation lesions on chest CT scans were also associated with a more extended hospitalization and recovery period. Conclusions: Initial assessment of COVID-19 patients, including symptoms, vital signs, and routine laboratory tests, can predict the severity of lung involvement and unfavorable outcomes.